Dr. Maggi developed his career as a researcher with interest in proteomics and molecular microbiology of microorganisms in complex environments. During the past 17 years, Dr. Maggi has been working at the North Carolina State University Vector-Borne Diseases Diagnostic Laboratory and at the Intracellular Pathogens Research Laboratory, characterizing vector-borne pathogens and zoonotic diseases. Dr. Maggi’s laboratory has focused on the development of new and enhanced serological, molecular, and microbiological methods for the detection and characterization of Anaplasma, Babesia, Borrelia, Ehrlichia, Mycoplasma, and Rickettsia infections in animals and humans. These efforts have resulted in new diagnostic modalities, such as the Bartonella-Alpha Proteobacteria Culture Medium (BAPGM) platform, a Babesia-Bartonella-Borrelia multiplex Droplet Digital PCR (ddPCR) assay, and the development of in-vitro non-tumorigenic epithelial human cell line model systems to gain mechanistic insights into altered cellular pathways, leading to angiogenesis, cancer induction, and inflammation. Dr. Maggi has over 140 manuscripts published in peer-review clinical and scientific journals.
Dr. Maggi developed his career as a researcher with interest in proteomics and molecular microbiology of microorganisms in complex environments. During the past 17 years, Dr. Maggi has been working at the North Carolina State University Vector-Borne Diseases Diagnostic Laboratory and at the Intracellular Pathogens Research Laboratory, characterizing vector-borne pathogens and zoonotic diseases. Dr. Maggi’s laboratory has focused on the development of new and enhanced serological, molecular, and microbiological methods for the detection and characterization of Anaplasma, Babesia, Borrelia, Ehrlichia, Mycoplasma, and Rickettsia infections in animals and humans. These efforts have resulted in new diagnostic modalities, such as the Bartonella-Alpha Proteobacteria Culture Medium (BAPGM) platform, a Babesia-Bartonella-Borrelia multiplex Droplet Digital PCR (ddPCR) assay, and the development of in-vitro non-tumorigenic epithelial human cell line model systems to gain mechanistic insights into altered cellular pathways, leading to angiogenesis, cancer induction, and inflammation. Dr. Maggi has over 140 manuscripts published in peer-review clinical and scientific journals.